Literature DB >> 6352494

In vivo function of hemolysin in the nephropathogenicity of Escherichia coli.

C Waalwijk, D M MacLaren, J de Graaff.   

Abstract

The role of hemolysin in the nephropathogenicity of Escherichia coli was studied in a hematogenous pyelonephritis model in mice. The nephropathogenicity of a nonhemolytic, avirulent E. coli strain was increased by simultaneous injection with its hemolytic, nephropathogenic parent. This helper mechanism could be attributed to hemolysin, since the simultaneous injection of partially purified hemolysin gave a similar enhancement of nephropathogenicity. Intraperitoneal injection of hemoglobin or iron sulfate before intravenous challenge with this avirulent strain also led to increased virulence. The nephropathogenicity-enhancing effect of hemolysin is therefore supposed to depend on increasing the level of available iron in the host. Under conditions of plentiful iron, hemolysin production was repressed, as shown by in vitro growth experiments in the presence of exogenous iron. These results suggest that the production of hemolysin is regulated by feedback inhibition.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6352494      PMCID: PMC264550          DOI: 10.1128/iai.42.1.245-249.1983

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  23 in total

1.  The haemolysins of Escherichia coli.

Authors:  H W SMITH
Journal:  J Pathol Bacteriol       Date:  1963-01

2.  Hemolysin plasmid coding for the virulence of a nephropathogenic Escherichia coli strain.

Authors:  C Waalwijk; J F van den Bosch; D M MacLaren; J de Graaff
Journal:  Infect Immun       Date:  1982-01       Impact factor: 3.441

3.  Effect of Escherichia coli alpha-hemolysin on human peripheral leukocyte viability in vitro.

Authors:  S J Cavalieri; I S Snyder
Journal:  Infect Immun       Date:  1982-05       Impact factor: 3.441

Review 4.  The significance of iron in infection.

Authors:  J J Bullen
Journal:  Rev Infect Dis       Date:  1981 Nov-Dec

5.  Haptoglobin biosynthesis in rats. Immunological identification of polysomes synthesizing haptoglobin and quantitation of haptoglobin in the cytoplasm of liver cells.

Authors:  F A Baglia; S W Kwan; G M Fuller
Journal:  Biochim Biophys Acta       Date:  1982-01-26

6.  Inactivation of haemolysin production in Escherichia coli by transposon insertion results in loss of virulence.

Authors:  C Waalwijk; J de Graaff
Journal:  Antonie Van Leeuwenhoek       Date:  1983-04       Impact factor: 2.271

7.  Haptoglobin: a natural bacteriostat.

Authors:  J W Eaton; P Brandt; J R Mahoney; J T Lee
Journal:  Science       Date:  1982-02-05       Impact factor: 47.728

8.  Effect of Escherichia coli alpha-hemolysin on human peripheral leukocyte function in vitro.

Authors:  S J Cavalieri; I S Snyder
Journal:  Infect Immun       Date:  1982-09       Impact factor: 3.441

9.  Effect of iron on acute pyelonephritis and later chronic changes.

Authors:  L B Guze; P A Guze; G M Kalmanson; R J Glassock
Journal:  Kidney Int       Date:  1982-06       Impact factor: 10.612

10.  The role of alpha haemolysin in the virulence of Escherichia coli for mice.

Authors:  M A Linggood; P L Ingram
Journal:  J Med Microbiol       Date:  1982-02       Impact factor: 2.472

View more
  41 in total

1.  The social evolution of bacterial pathogenesis.

Authors:  J Smith
Journal:  Proc Biol Sci       Date:  2001-01-07       Impact factor: 5.349

2.  Partial purification of alpha-hemolysin in Escherichia coli.

Authors:  F Nistiar; V Janigová; J Durovicová; H Puzová
Journal:  Folia Microbiol (Praha)       Date:  1991       Impact factor: 2.099

Review 3.  The different hemolysins of Escherichia coli.

Authors:  L Beutin
Journal:  Med Microbiol Immunol       Date:  1991       Impact factor: 3.402

Review 4.  Escherichia coli in extra-intestinal infections.

Authors:  I Orskov; F Orskov
Journal:  J Hyg (Lond)       Date:  1985-12

Review 5.  Role of pore-forming toxins in bacterial infectious diseases.

Authors:  Ferdinand C O Los; Tara M Randis; Raffi V Aroian; Adam J Ratner
Journal:  Microbiol Mol Biol Rev       Date:  2013-06       Impact factor: 11.056

6.  Incidence of aerobactin-positive Escherichia coli strains in patients with symptomatic urinary tract infection.

Authors:  S H Jacobson; M Hammarlind; K J Lidefeldt; E Osterberg; K Tullus; A Brauner
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-10       Impact factor: 3.267

7.  Hemolytic activity of Serratia marcescens.

Authors:  V Braun; H Günther; B Neuss; C Tautz
Journal:  Arch Microbiol       Date:  1985-05       Impact factor: 2.552

8.  In vitro cytotoxic effect of alpha-hemolytic Escherichia coli on human blood granulocytes.

Authors:  O V Gadeberg; I Orskov
Journal:  Infect Immun       Date:  1984-07       Impact factor: 3.441

9.  Identification with monoclonal antibodies of hemolysin produced by clinical isolates of Escherichia coli.

Authors:  F Hugo; M Arvand; J Reichwein; N Mackman; I B Holland; S Bhakdi
Journal:  J Clin Microbiol       Date:  1987-01       Impact factor: 5.948

10.  Iron-repressible outer membrane proteins of Helicobacter pylori involved in heme uptake.

Authors:  D J Worst; B R Otto; J de Graaff
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.